ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic reti... de réir Sammons, E, Bowman, L, Stevens, W, Buck, G, Wallendszus, K, Hammami, I, Parish, S, Armitage, J

Rannpháirtithe: “…ASCEND Collaborative Group …”

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial de réir Aung, T, Buck, GAN, Parish, S, Bowman, L, Armitage, J

Rannpháirtithe: “…The ASCEND Collaborative Group…”